REPLIGEN CORP - COMMON STOCK (RGEN)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,095,854
Total 13F shares
48,677,414
Share change
+1,409,728
Total reported value
$9,149,179,277
Put/Call ratio
128%
Price per share
$188.09
Number of holders
431
Value change
+$200,963,724
Number of buys
206
Number of sells
227

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2022

As of 31 Mar 2022, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 431 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,677,414 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., BROWN CAPITAL MANAGEMENT LLC, WCM INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, AMERIPRISE FINANCIAL INC, ALLIANCEBERNSTEIN L.P., and MACQUARIE GROUP LTD. This page lists 431 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.